{"id":33240,"date":"2025-05-13T12:24:54","date_gmt":"2025-05-13T04:24:54","guid":{"rendered":"https:\/\/flcube.com\/?p=33240"},"modified":"2025-05-13T12:29:48","modified_gmt":"2025-05-13T04:29:48","slug":"eastenova-biotechnology-makes-hong-kong-ipo-debut-with-regenerative-medicine-focus","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=33240","title":{"rendered":"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus"},"content":{"rendered":"\n<p>China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to the Hong Kong Stock Exchange. Key details, including the unit price, remain undisclosed at this stage. CCB International is acting as the sole sponsor for the offering.<\/p>\n\n\n\n<p><strong>Company Overview<\/strong><br>Founded in 2016, Eastenova is dedicated to the research and development, manufacturing, and commercialization of regenerative medicine medical devices and foods for special medical purpose (FSMP). The company&#8217;s regenerative medicine material pipeline includes 13 injectable candidates and 8 dressings\/patches. Its FSMP pipeline comprises two approved products: XIQIN, a pre-surgery carbohydrate supplement, and Xihongyuan, an electrolyte supplement.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/sehk25051201216_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk25051201216_c.\"><\/object><a id=\"wp-block-file--media-c366af16-19a3-4864-8082-bd6d2a6975b8\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/sehk25051201216_c.pdf\">sehk25051201216_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/sehk25051201216_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-c366af16-19a3-4864-8082-bd6d2a6975b8\">Download<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/sehk25051201289.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk25051201289.\"><\/object><a id=\"wp-block-file--media-33285bb0-b48b-4b32-9b35-d7ee6e9adb10\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/sehk25051201289.pdf\">sehk25051201289<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/sehk25051201289.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-33285bb0-b48b-4b32-9b35-d7ee6e9adb10\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":33247,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4060,72],"class_list":["post-33240","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-eastenova-biotechnology","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to the Hong Kong Stock Exchange. Key details, including the unit price, remain undisclosed at this stage. CCB International is acting as the sole sponsor for the offering.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=33240\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus\" \/>\n<meta property=\"og:description\" content=\"China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to the Hong Kong Stock Exchange. Key details, including the unit price, remain undisclosed at this stage. CCB International is acting as the sole sponsor for the offering.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=33240\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-13T04:24:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-13T04:29:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1303-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus\",\"datePublished\":\"2025-05-13T04:24:54+00:00\",\"dateModified\":\"2025-05-13T04:29:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240\"},\"wordCount\":119,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1303-1.webp\",\"keywords\":[\"Eastenova Biotechnology\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=33240#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=33240\",\"name\":\"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1303-1.webp\",\"datePublished\":\"2025-05-13T04:24:54+00:00\",\"dateModified\":\"2025-05-13T04:29:48+00:00\",\"description\":\"China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to the Hong Kong Stock Exchange. Key details, including the unit price, remain undisclosed at this stage. CCB International is acting as the sole sponsor for the offering.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=33240\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1303-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1303-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33240#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus - Insight, China&#039;s Pharmaceutical Industry","description":"China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to the Hong Kong Stock Exchange. Key details, including the unit price, remain undisclosed at this stage. CCB International is acting as the sole sponsor for the offering.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=33240","og_locale":"en_US","og_type":"article","og_title":"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus","og_description":"China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to the Hong Kong Stock Exchange. Key details, including the unit price, remain undisclosed at this stage. CCB International is acting as the sole sponsor for the offering.","og_url":"https:\/\/flcube.com\/?p=33240","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-13T04:24:54+00:00","article_modified_time":"2025-05-13T04:29:48+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1303-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=33240#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=33240"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus","datePublished":"2025-05-13T04:24:54+00:00","dateModified":"2025-05-13T04:29:48+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=33240"},"wordCount":119,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=33240#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1303-1.webp","keywords":["Eastenova Biotechnology","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=33240#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=33240","url":"https:\/\/flcube.com\/?p=33240","name":"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=33240#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=33240#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1303-1.webp","datePublished":"2025-05-13T04:24:54+00:00","dateModified":"2025-05-13T04:29:48+00:00","description":"China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to the Hong Kong Stock Exchange. Key details, including the unit price, remain undisclosed at this stage. CCB International is acting as the sole sponsor for the offering.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=33240#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=33240"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=33240#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1303-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1303-1.webp","width":1080,"height":608,"caption":"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=33240#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1303-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33240"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33240\/revisions"}],"predecessor-version":[{"id":33245,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33240\/revisions\/33245"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/33247"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}